Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Print yourself - Towards 3D Bioprinted Organs - Skin

Reference number
Coordinator CHALMERS TEKNISKA HÖGSKOLA AKTIEBOLAG - Institutionen för kemi och kemiteknik
Funding from Vinnova SEK 500 000
Project duration May 2016 - December 2016
Status Completed
Venture Challenge-Driven Innovation – Stage 1 initiation

Purpose and goal

The aim of the project is to develop a model of human skin with 3D Bioprinting technology. The model will be materialized in Phase 2 and evaluated by health care, academy and industry. A successful project will lead to better health especially for the elderly population. We have formed a very competent, equal and interdisciplinary consortium consisting of large and small companies, academy and health care providers. We will together develop the 3D Bioprinting technology to produce and commercialize living skin.

Expected results and effects

The goal of our consortium is a human skin model fabricated with 3D Bioprinting technology that well represent aged skin and can be used as a model for evaluation of skin care products. These skin models will lead to development of better products which will improve life quality for the elderly population and at the same time create successful new products which can be sold on the global market. We will also develop the 3D Bioprinting technology to be used in the clinic, primary for treatment of burn wounds but later on for chronical wounds as well.

Planned approach and implementation

During the project a skin model has been 3D Bioprinted. The functionality of the skin has been verified with confocal microscopy which showed that the cells are alive after the process. More verification is needed and in next phase of the project we aim to add functionalities requested by the end users. We have met in several workshops with international scientists from industry and academia and mapped out the international status of the technology and regulatory requirements. We have a draft of the consortium agreement, which regulate IP and allows commercialization.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2016-00516

Page statistics